 | • レポートコード：MRC2302A090P • 出版社/出版日：360iResearch / 2023年2月1日 • レポート形態：英語、PDF、240ページ • 納品方法：Eメール（受注後3日） • 産業分類：実験機器 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社発行の当調査レポートでは、2021年に8,638.55百万ドルであった世界の細胞分離/セル分離市場規模が、2022年に9,976.06百万ドルに達し、2027年には20,679.59百万ドルまで年平均15.66％で成長すると予測しています。当レポートは、細胞分離/セル分離の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（消耗品、機器）分析、細胞タイプ別（動物細胞、ヒト細胞）分析、細胞ソース別（脂肪組織、骨髄、臍帯血/胚性幹細胞）分析、技術別（遠心分離技術（細胞分離）、ろ過技術（細胞分離）、表面マーカー技術（細胞分離））分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況など、以下の構成でまとめております。なお、当書には、Akadeum Life Sciences, Inc.、Alfa Laval、Beckman Coulter Inc.、Becton, Dickinson and Company、Bio Legend、Bio- Techne、Bio-Rad Laboratories, Inc.、Cell Biologics, Inc. A、Cell Microsystems、cellenion SASU、Corning Inc.、GE Healthcare、Invent Biotechnologies、Lonzaなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の細胞分離/セル分離市場規模：製品別 - 消耗品の市場規模 - 機器の市場規模 ・世界の細胞分離/セル分離市場規模：細胞タイプ別 - 動物細胞の市場規模 - ヒト細胞の市場規模 ・世界の細胞分離/セル分離市場規模：技術別 - 遠心分離技術（細胞分離）の市場規模 - ろ過技術（細胞分離）の市場規模 - 表面マーカー技術（細胞分離）の市場規模 ・世界の細胞分離/セル分離市場規模：地域別 - 南北アメリカの細胞分離/セル分離市場規模 アメリカの細胞分離/セル分離市場規模 カナダの細胞分離/セル分離市場規模 ブラジルの細胞分離/セル分離市場規模 ... - アジア太平洋の細胞分離/セル分離市場規模 日本の細胞分離/セル分離市場規模 中国の細胞分離/セル分離市場規模 インドの細胞分離/セル分離市場規模 韓国の細胞分離/セル分離市場規模 台湾の細胞分離/セル分離市場規模 ... - ヨーロッパ/中東/アフリカの細胞分離/セル分離市場規模 イギリスの細胞分離/セル分離市場規模 ドイツの細胞分離/セル分離市場規模 インドの細胞分離/セル分離市場規模 フランスの細胞分離/セル分離市場規模 ロシアの細胞分離/セル分離市場規模 ... - その他地域の細胞分離/セル分離市場規模 ・競争状況 ・企業情報 |
The Global Cell Isolation/Cell Separation Market size was estimated at USD 8,638.55 million in 2021 and expected to reach USD 9,976.06 million in 2022, and is projected to grow at a CAGR 15.66% to reach USD 20,679.59 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Cell Isolation/Cell Separation to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Consumables and Instruments. The Consumables is further studied across Beads, Disposables, and Reagents, Kits, Media, and Sera. The Instruments is further studied across Centrifuges, Filtration Systems, Flow Cytometers, and Magnetic-Activated Cell Separator Systems.
Based on Cell Type, the market was studied across Animal Cells and Human Cells. The Human Cells is further studied across Differentiated Cells and Stem Cells.
Based on Cell Source, the market was studied across Adipose Tissue, Bone Marrow, and Cord Blood/Embryonic Stem Cells.
Based on Technique, the market was studied across Centrifugation-Based Cell Isolation, Filtration-Based Cell Isolation, and Surface Marker-Based Cell Isolation.
Based on Application, the market was studied across Biomolecule Isolation, Cancer Research, In Vitro Diagnostics, Stem Cell Research, and Tissue Regeneration & Regenerative Medicine.
Based on End User, the market was studied across Biotechnology & Biopharmaceutical Companies, Hospitals & Diagnostic Laboratories, and Research Laboratories & Institutes.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cell Isolation/Cell Separation market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Isolation/Cell Separation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Isolation/Cell Separation Market, including Akadeum Life Sciences, Inc., Alfa Laval, Beckman Coulter Inc., Becton, Dickinson and Company, Bio Legend, Bio- Techne, Bio-Rad Laboratories, Inc., Cell Biologics, Inc. A, Cell Microsystems, cellenion SASU, Corning Inc., GE Healthcare, Invent Biotechnologies, Lonza, Merck KGaA, Miltenyl Biotech, Omega Bio-tek, Inc., pluriSelect Life Science, Pluriselect Life Science Ug (Haftungsbeschränkt) & Co. Kg, REPROCELL Inc., Roche Diagnostics, Stemcell Technologies, Inc., Terumo Bct, and Thermo Fisher Scientific, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Cell Isolation/Cell Separation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Isolation/Cell Separation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Isolation/Cell Separation Market?
4. What is the competitive strategic window for opportunities in the Global Cell Isolation/Cell Separation Market?
5. What are the technology trends and regulatory frameworks in the Global Cell Isolation/Cell Separation Market?
6. What is the market share of the leading vendors in the Global Cell Isolation/Cell Separation Market?
7. What modes and strategic moves are considered suitable for entering the Global Cell Isolation/Cell Separation Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Government funding supporting cell-based research
5.1.1.2. Increasing number of patients suffering from cancer and infectious diseases
5.1.1.3. Technological advancements in cell isolation processes
5.1.2. Restraints
5.1.2.1. High cost of cell-based research
5.1.3. Opportunities
5.1.3.1. Growing focus on personalized medicine and targeted therapies
5.1.3.2. Development of automated technologies for cell-based therapeutics and bioprocessing
5.1.4. Challenges
5.1.4.1. Ethical issues related to embryonic stem cell isolation
5.2. Cumulative Impact of COVID-19
6. Cell Isolation/Cell Separation Market, by Product
6.1. Introduction
6.2. Consumables
6.3.1. Beads
6.3.2. Disposables
6.3.3. Reagents, Kits, Media, and Sera
6.3. Instruments
6.4.1. Centrifuges
6.4.2. Filtration Systems
6.4.3. Flow Cytometers
6.4.4. Magnetic-Activated Cell Separator Systems
7. Cell Isolation/Cell Separation Market, by Cell Type
7.1. Introduction
7.2. Animal Cells
7.3. Human Cells
7.4.1. Differentiated Cells
7.4.2. Stem Cells
8. Cell Isolation/Cell Separation Market, by Cell Source
8.1. Introduction
8.2. Adipose Tissue
8.3. Bone Marrow
8.4. Cord Blood/Embryonic Stem Cells
9. Cell Isolation/Cell Separation Market, by Technique
9.1. Introduction
9.2. Centrifugation-Based Cell Isolation
9.3. Filtration-Based Cell Isolation
9.4. Surface Marker-Based Cell Isolation
10. Cell Isolation/Cell Separation Market, by Application
10.1. Introduction
10.2. Biomolecule Isolation
10.3. Cancer Research
10.4. In Vitro Diagnostics
10.5. Stem Cell Research
10.6. Tissue Regeneration & Regenerative Medicine
11. Cell Isolation/Cell Separation Market, by End User
11.1. Introduction
11.2. Biotechnology & Biopharmaceutical Companies
11.3. Hospitals & Diagnostic Laboratories
11.4. Research Laboratories & Institutes
12. Americas Cell Isolation/Cell Separation Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Cell Isolation/Cell Separation Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Cell Isolation/Cell Separation Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Akadeum Life Sciences, Inc.
16.1.1. Business Overview
16.1.2. Key Executives
16.1.3. Product & Services
16.2. Alfa Laval
16.2.1. Business Overview
16.2.2. Key Executives
16.2.3. Product & Services
16.3. Beckman Coulter Inc.
16.3.1. Business Overview
16.3.2. Key Executives
16.3.3. Product & Services
16.4. Becton, Dickinson and Company
16.4.1. Business Overview
16.4.2. Key Executives
16.4.3. Product & Services
16.5. Bio Legend
16.5.1. Business Overview
16.5.2. Key Executives
16.5.3. Product & Services
16.6. Bio- Techne
16.6.1. Business Overview
16.6.2. Key Executives
16.6.3. Product & Services
16.7. Bio-Rad Laboratories, Inc.
16.7.1. Business Overview
16.7.2. Key Executives
16.7.3. Product & Services
16.8. Cell Biologics, Inc. A
16.8.1. Business Overview
16.8.2. Key Executives
16.8.3. Product & Services
16.9. Cell Microsystems
16.9.1. Business Overview
16.9.2. Key Executives
16.9.3. Product & Services
16.10. cellenion SASU
16.10.1. Business Overview
16.10.2. Key Executives
16.10.3. Product & Services
16.11. Corning Inc.
16.11.1. Business Overview
16.11.2. Key Executives
16.11.3. Product & Services
16.12. GE Healthcare
16.12.1. Business Overview
16.12.2. Key Executives
16.12.3. Product & Services
16.13. Invent Biotechnologies
16.13.1. Business Overview
16.13.2. Key Executives
16.13.3. Product & Services
16.14. Lonza
16.14.1. Business Overview
16.14.2. Key Executives
16.14.3. Product & Services
16.15. Merck KGaA
16.15.1. Business Overview
16.15.2. Key Executives
16.15.3. Product & Services
16.16. Miltenyl Biotech
16.16.1. Business Overview
16.16.2. Key Executives
16.16.3. Product & Services
16.17. Omega Bio-tek, Inc.
16.17.1. Business Overview
16.17.2. Key Executives
16.17.3. Product & Services
16.18. pluriSelect Life Science
16.18.1. Business Overview
16.18.2. Key Executives
16.18.3. Product & Services
16.19. Pluriselect Life Science Ug (Haftungsbeschränkt) & Co. Kg
16.19.1. Business Overview
16.19.2. Key Executives
16.19.3. Product & Services
16.20. REPROCELL Inc.
16.20.1. Business Overview
16.20.2. Key Executives
16.20.3. Product & Services
16.21. Roche Diagnostics
16.21.1. Business Overview
16.21.2. Key Executives
16.21.3. Product & Services
16.22. Stemcell Technologies, Inc.
16.22.1. Business Overview
16.22.2. Key Executives
16.22.3. Product & Services
16.23. Terumo Bct
16.23.1. Business Overview
16.23.2. Key Executives
16.23.3. Product & Services
16.24. Thermo Fisher Scientific, Inc.
16.24.1. Business Overview
16.24.2. Key Executives
16.24.3. Product & Services
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing